Wells Fargo Upgrades Globus Medical (GMED) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Globus Medical Reports Second Quarter 2016 Results
July 26, 2016 4:30 PM EDTAUDUBON, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016.
Worldwide sales increased 2.9% as reported to $137.5 million, or 3.1% on a constant currency basisSecond quarter net income increased 7.3% to $25.8 million, or 18.8% of salesDiluted earnings per share (EPS) increased 6.9% to $0.27Non-GAAP diluted EPS increased 10.6% to $0.29Non-GAAP Adjusted EBITDA (AEBITDA) was 36.5% of salesCompany issues new 2016 guidance for sales of $575 millionDavid Paul, Chairman and CEO said, Second quarter sales... More
